工业生物技术专刊序言

以生物催化和生物转化为核心的工业生物技术是实现社会和经济可持续发展的有效手段。本期专刊分别从基因工程、代谢工程与合成生物学、生理工程、发酵工程与生化工程、生物催化与生物转化、生物技术与方法等方面,介绍了我国在工业生物技术领域的最新研究进展。     

工业生物技术的前沿科技

随着石化资源逐步消耗,气候问题日益凸显,工业生物技术被认为是解决能源和资源供给、应对气候变化、实现绿色可持续发展的重要方向。得益于理论突破、技术变革和学科交叉,工业生物技术主要经历了由生命科学突破性成就、多学科技术理念交汇融合和产业应用导向推动的3个阶段。本文回顾总结了工业生物技术的发展历程及近年来取得的重要突破,并展望了其未来发展方向。     

生物催化与生物转化研究进展

由于生物催化过程具有高效、高选择性、条件温和、环境友好等优点,因此成为可持续发展过程中替代和拓展传统有机化学合成的重要方法。近两年的进展集中于新生物催化剂的发现和改造,以及将生物催化和生物转化应用于工业过程的探索,包括开发新的反应体系,新的固定化方法等。可以预见,在医药中间体等高附加值化工产品的生产过程中,生物催化和生物转化的应用将呈现加速增长趋势。     

后基因组时代的工业生物技术

简述了工业生物技术的发展背景和意义,分析了基因组学和功能基因组学发展对工业生物技术的推动作用,重点介绍了本期专刊发表的代谢工程、发酵工程以及工业酶与生物催化领域的17篇论文。     

13C代谢流量分析发展30年

13C代谢流量分析(13C metabolic flux analysis,13C-MFA),是通过标记实验分析蛋白氨基酸或胞内代谢物同位素标记异构体的分布情况,从而准确定量胞内反应速率.该技术在系统理解细胞代谢特性、指导代谢工程改造和揭示病理生理学等方面起着重要作用,引起研究者的广泛重视.文中重点综述了代谢流分析30...     

聚羟基脂肪酸酯PHA代谢工程研究30年

聚羟基脂肪酸酯(Polyhydroxyalkanoate,PHA)是微生物合成的可降解高分子材料,种类及性能多样,应用前景广阔,然而其大规模生产受制于它较为高昂的生产成本.30年来,代谢工程的应用日益广泛,通过代谢流调控、代谢通路改造引入新通路等方法,微生物合成PHA的效率得到了很大提高,也丰富了PHA的单体种类、结构...     

冲击生物技术第三次浪潮

工业生物催化是继医药、农业之后的生物技术第三次浪潮。从21世纪化学工业发展的前沿特点,介绍生物催化加工过程及生产方式,主要解决传统产业改造和新的应用领域的开拓,提出发展生物催化产业的策略和加强支持力度的建设。     

Production of a pharmaceutical intermediate via biohydroxylation using whole cells of Rhodococcus rubropertinctus N82

Rhodococcus rubropertinctus N82 possesses unique regiospecific hydroxylation activity in biotransformation of compounds. In this study, the ability of whole cells of the strain R. rubropertinctus N82 in biotransformation was studied. The hydroxylation activity resulted in transforming 6,7-dihydro-4H-thieno[3,2-c]-pyridine-5-carboxylic acid tert-butyl ester (LS1) into 2-hydroxy-6,7-dihydro-4H-thieno[3,2-c]-pyridine-5-carboxylic acid tert-butyl ester (LP1), a pharmaceutical intermediate. By optimizing conditions for the hydroxylating biotransformation using whole cells of R. rubropertinctus N82 as biocatalyst, 3.3?mM LP1 was successfully produced from 4?mM LS1 with a molar yield of 83%. Thus, effective method was newly developed to produce LP1, which is a synthetic intermediate of a platelet inhibitor active pharmaceutical ingredient drug, prasugrel.     

Impact of systems biology on metabolic engineering of Saccharomyces cerevisiae

Industrial biotechnology is a rapidly growing field. With the increasing shift towards a bio-based economy, there is rising demand for developing efficient cell factories that can produce fuels, chemicals, pharmaceuticals, materials, nutraceuticals, and even food ingredients. The yeast Saccharomyces cerevisiae is extremely well suited for this objective. As one of the most intensely studied eukaryotic model organisms, a rich density of knowledge detailing its genetics, biochemistry, physiology, and large-scale fermentation performance can be capitalized upon to enable a substantial increase in the industrial application of this yeast. Developments in genomics and high-throughput systems biology tools are enhancing one's ability to rapidly characterize cellular behaviour, which is valuable in the field of metabolic engineering where strain characterization is often the bottleneck in strain development programmes. Here, the impact of systems biology on metabolic engineering is reviewed and perspectives on the role of systems biology in the design of cell factories are given.     

Alkane activation by P450 oxygenases

The hydroxylation of alkane molecules, especially at terminal positions, is a challenging reaction. Enzymes that catalyze this reaction could be used to produce high-value compounds from aliphatic and alkyl-substituted substrates. However, until a few years ago, all known alkane hydroxylating enzymes were membrane-bound, and difficult to use. Recently, three bacterial P450 enzymes of the (soluble) CYP101 and CYP102 families were engineered to hydroxylate alkanes, but even after extensive efforts hydroxylation was mainly at sub-terminal positions. More recently, a new soluble P450 family (CYP153) was identified and characterized, which activates the terminal position of alkanes and alkyl-substituted compounds with very high regio-selectivity. The use of CYP153s in biotechnological applications is now being explored.     

2013生物基化学品 (Biobased Chemicals) 专刊序言

生物基化学品是生物经济和生物制造的核心内容之一。本专刊综述了国内外生物基化学品的重要研究进展,包括：丁二酸、己二酸、乳酸、3-羟基丙酸、葡萄糖二酸、甘油、木糖醇、高级醇、乙烯等生物基化学品的代谢工程和发酵调控,直接利用木质纤维素生产生物基化学品的菌株构建,生物基乳酸的衍生和生物转化技术,生物基化学品的盐析萃取分离纯化技术等。同时,本专刊也包括了国内学者在丁二酸、D-甘露醇、苹果酸、5-氨基乙酰丙酸、1,3-丙二醇和丁醇方面的研究论文。